{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T03:57:16Z","timestamp":1777780636502,"version":"3.51.4"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2018MC010"],"award-info":[{"award-number":["ZR2018MC010"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.micpath.2025.108060","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:04:33Z","timestamp":1758582273000},"page":"108060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Advance Helicobacter pylori eradication: Current therapeutic strategies and the potential of lipid-based nanocarriers for targeting receptors"],"prefix":"10.1016","volume":"209","author":[{"given":"Mohamed","family":"Sharaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tehsin Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Guang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1080\/14656566.2020.1845649","article-title":"An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection","volume":"22","author":"Georgopoulos","year":"2021","journal-title":"Expet Opin. Pharmacother."},{"issue":"16","key":"10.1016\/j.micpath.2025.108060_bib2","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.3748\/wjg.v23.i16.2870","article-title":"Strategies used by helicobacter pylori to establish persistent infection","volume":"23","author":"Abadi","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"issue":"46","key":"10.1016\/j.micpath.2025.108060_bib4","article-title":"Synergistic antimicrobial capability of magnetically oriented graphene oxide conjugated with gold nanoclusters","volume":"29","author":"Zheng","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.micpath.2025.108060_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.msec.2017.08.038","article-title":"Development of novel pH-sensitive thiolated chitosan\/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori","volume":"83","author":"Arif","year":"2018","journal-title":"Mater. Sci. Eng. C"},{"issue":"22","key":"10.1016\/j.micpath.2025.108060_bib6","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.2174\/092986712801661167","article-title":"New therapeutic approaches by using microorganism-derived compounds","volume":"19","author":"Amedei","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.micpath.2025.108060_bib7","series-title":"Potential Utility of Nano-Based Treatment Approaches to Address the Risk of Helicobacter pylori, Expert Review of Anti-infective Therapy","first-page":"1","author":"Khan","year":"2021"},{"key":"10.1016\/j.micpath.2025.108060_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.meegid.2018.02.022","article-title":"Genetic populations and virulence factors of Helicobacter pylori","volume":"60","author":"Kabamba","year":"2018","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.micpath.2025.108060_bib9","first-page":"321","article-title":"Nanosystems for drug delivery: design, engineering, and applications, green synthesis, characterization and applications of nanoparticles","author":"Dhapte","year":"2019","journal-title":"Elsevier"},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib10","first-page":"683","article-title":"Application of nanodrug delivery systems in enhancing treatment of gastritis and gastric cancer: a systematic evaluation of targeted therapy","volume":"17","author":"Xu","year":"2025"},{"key":"10.1016\/j.micpath.2025.108060_bib11","first-page":"1","article-title":"Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections","author":"de Souza","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib12","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2025.108060_bib14","series-title":"A Report Card to Grade Helicobacter pylori Therapy","author":"Graham","year":"2007"},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht IV\/Florence consensus report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12475","article-title":"Fifth Chinese national consensus report on the management of Helicobacter pylori infection","volume":"23","author":"Liu","year":"2018","journal-title":"Helicobacter"},{"key":"10.1016\/j.micpath.2025.108060_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ejmech.2013.07.023","article-title":"Helicobacter pylori inactivation and virulence gene damage using a supported sensitiser for photodynamic therapy","volume":"68","author":"Calvino-Fern\u00e1ndez","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10103-006-0409-7","article-title":"Anti-microbial photodynamic therapy: useful in the future?","volume":"22","author":"Maisch","year":"2007","journal-title":"Laser Med. Sci."},{"key":"10.1016\/j.micpath.2025.108060_bib20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jphotobiol.2014.09.015","article-title":"In vitro studies of different irradiation conditions for photodynamic inactivation of Helicobacter pylori","volume":"141","author":"Simon","year":"2014","journal-title":"J. Photochem. Photobiol. B Biol."},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib21","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1109\/TMECH.2016.2536944","article-title":"An ingestible capsule for the photodynamic therapy of helicobacter pylori infection","volume":"21","author":"Tortora","year":"2016","journal-title":"IEEE ASME Trans. Mechatron."},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/lsm.20161","article-title":"Helicobacter pylori in patients can be killed by visible light","volume":"36","author":"Ganz","year":"2005","journal-title":"Laser Surg. Med.: Off. J. Am. Soc. Laser Med. Surg."},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/lsm.20770","article-title":"Treatment of Helicobacter pylori infection with intra\u2010gastric violet light phototherapy: a pilot clinical trial","volume":"41","author":"Lembo","year":"2009","journal-title":"Laser Surg. Med.: Off. J. Am. Soc. Laser Med. Surg."},{"key":"10.1016\/j.micpath.2025.108060_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fmicb.2020.00283","article-title":"The in vitro photoinactivation of Helicobacter pylori by a novel LED-based device","volume":"11","author":"Morici","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.108060_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2021.112287","article-title":"Selective photodynamic inactivation of Helicobacter pylori by a cationic benzylidene cyclopentanone photosensitizer-an in vitro and ex vivo study","volume":"223","author":"Wang","year":"2021","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.micpath.2025.108060_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120745","article-title":"Helicobacter pylori-targeting multiligand photosensitizer for effective antibacterial endoscopic photodynamic therapy","volume":"271","author":"Im","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.micpath.2025.108060_bib27","author":"Joint"},{"key":"10.1016\/j.micpath.2025.108060_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/594561","article-title":"Long-term use of probiotic-containing yogurts is a safe way to prevent Helicobacter pylori: based on a Mongolian gerbil's model","volume":"2013","author":"Kuo","year":"2013","journal-title":"Biochem. Res. Int."},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib29","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1128\/AEM.01820-10","article-title":"Novel probiotic Bifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori","volume":"77","author":"Chenoll","year":"2011","journal-title":"Appl. Environ. Microbiol."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib30","first-page":"973","article-title":"biotechnology, Effect of the oral intake of probiotic Pediococcus acidilactici BA28 on Helicobacter pylori causing peptic ulcer in C57BL\/6 mice models","volume":"172","author":"Kaur","year":"2014"},{"issue":"11","key":"10.1016\/j.micpath.2025.108060_bib31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12275-014-4355-y","article-title":"Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infection","volume":"52","author":"Kim","year":"2014","journal-title":"J. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/hel.12203","article-title":"Mouse models for assessing the protective efficacy of Lactobacillus gasseri SBT 2055 against Helicobacter suis infection associated with the development of gastric mucosa\u2010associated lymphoid tissue lymphoma","volume":"20","author":"Matsui","year":"2015","journal-title":"Helicobacter"},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib33","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3168\/jds.2015-10510","article-title":"Changes in gastric microbiota induced by Helicobacter pylori infection and preventive effects of Lactobacillus plantarum ZDY 2013 against such infection","volume":"99","author":"Pan","year":"2016","journal-title":"J. Dairy Sci."},{"issue":"21","key":"10.1016\/j.micpath.2025.108060_bib34","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.3748\/wjg.v21.i21.6561","article-title":"Probiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis","volume":"21","author":"Yu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.micpath.2025.108060_bib35","first-page":"4","article-title":"Azizalah Ebrahimi1, zahra aeini and davoud esmaeili, evaluation of the effect of Lactobacillus planetarium probiotics produced from broad bean seed in prevention of Helicobacter pylori in stomach tissue of C57bl\/6 mice","volume":"10","author":"Amin Afsahi","year":"2018","journal-title":"J. Cancer Sci. Ther."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib36","first-page":"116","article-title":"Design of a novel gut bacterial adhesion model for probiotic applications, Artificial cells","volume":"41","author":"Rodes","year":"2013","journal-title":"nanomedicine, and biotechnology"},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4014\/jmb.1205.05018","article-title":"Effect of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an in vitro study using a human colonic microbiota model","volume":"23","author":"Rodes","year":"2013","journal-title":"J. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/mbo3.252","article-title":"A highly acid\u2010resistant novel strain of Lactobacillus johnsonii No. 1088 has antibacterial activity, including that against Helicobacter pylori, and inhibits gastrin\u2010mediated acid production in mice","volume":"4","author":"Aiba","year":"2015","journal-title":"Microbiologyopen"},{"issue":"29","key":"10.1016\/j.micpath.2025.108060_bib39","doi-asserted-by":"crossref","first-page":"9898","DOI":"10.3748\/wjg.v20.i29.9898","article-title":"Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance","volume":"20","author":"Papastergiou","year":"2014","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib40","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4291\/wjgp.v5.i4.392","article-title":"Treatment of Helicobacter pylori infection: past, present and future","volume":"5","author":"Papastergiou","year":"2014","journal-title":"World J. Gastrointest. Pathophysiol."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib41","first-page":"73","article-title":"Lactic acid bacteria as probiotics","volume":"7","author":"Ljungh","year":"2006","journal-title":"Curr. Issues Intest. Microbiol."},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib42","first-page":"429","article-title":"Clinical application of probiotics in the treatment of Helicobacter pylori infection\u2014a brief review, Journal of Microbiology","volume":"47","author":"Patel","year":"2014","journal-title":"Immunol. Infection"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00253-017-8535-7","article-title":"Helicobacter pylori treatment: antibiotics or probiotics","volume":"102","author":"Goderska","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"45","key":"10.1016\/j.micpath.2025.108060_bib44","doi-asserted-by":"crossref","first-page":"8168","DOI":"10.3748\/wjg.v19.i45.8168","article-title":"How antibiotic resistances could change Helicobacter pylori treatment: a matter of geography?","volume":"19","author":"Ierardi","year":"2013","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1572-0241.2007.01085.x","article-title":"Helicobacter pylori eradication: a randomized prospective study of triple therapy: versus: triple therapy plus lactoferrin and probiotics","volume":"102","author":"De Bortoli","year":"2007","journal-title":"Official J. Am. Collegen Gastroenterol. ACG"},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/1319-3767.111953","article-title":"Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy?, Saudi Journal of Gastroenterology","volume":"19","author":"Dajani","year":"2013","journal-title":"Off. J. Saudi Gastroenterol. Assoc."},{"key":"10.1016\/j.micpath.2025.108060_bib47","unstructured":"INVALID CITATION !!!)."},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib48","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MCG.0000000000000007","article-title":"Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study","volume":"48","author":"Francavilla","year":"2014","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.micpath.2025.108060_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6237239","article-title":"Helicobacter pylori infection and gastric dysbiosis: can probiotics administration be useful to treat this condition?","volume":"2018","author":"Bruno","year":"2018","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.108060_bib50","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.3389\/fimmu.2020.02192","article-title":"Probiotics in medicine: a long debate","volume":"11","author":"Stavropoulou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2025.108060_bib51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mhp.2017.01.003","article-title":"Mechanism of development of depression and probiotics as adjuvant therapy for its prevention and management","volume":"5","author":"Gayathri","year":"2017","journal-title":"Mental Health Prevention"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.12998\/wjcc.v4.i1.5","article-title":"Treatment of Helicobacter pylori infection: current and future insights","volume":"4","author":"Safavi","year":"2016","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.micpath.2025.108060_bib53","first-page":"1","article-title":"Gastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: safety and efficacy assessment","volume":"13","author":"Xie","year":"2013","journal-title":"BMC Compl. Alternative Med."},{"issue":"8","key":"10.1016\/j.micpath.2025.108060_bib54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2174\/1389557520666191227151939","article-title":"Medicinal plants in the treatment of peptic ulcer disease: a review","volume":"20","author":"Ardalani","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.52547\/pbp.2.2.38","article-title":"Helicobacter phytotherapy: medicinal plants affecting Helicobacter pylori infection in Iran","volume":"2","author":"Salahvarzi","year":"2020","journal-title":"Plant Biotechnol. Persa"},{"key":"10.1016\/j.micpath.2025.108060_bib56","first-page":"138","volume":"vol. 157","author":"Reddy","year":"2023"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib57","first-page":"109","article-title":"Plant-based polyphenols: anti-Helicobacter pylori effect and improvement of gut microbiota","volume":"11","author":"Guerra-Valle","year":"2022"},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib58","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/molecules22050786","article-title":"Anti-helicobacter pylori activity of isocoumarin paepalantine: morphological and molecular docking analysis","volume":"22","author":"Damasceno","year":"2017","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib59","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1021\/acsomega.0c04763","article-title":"Epigallocatechin gallate with potent anti-Helicobacter pylori activity binds efficiently to its histone-like DNA binding protein","volume":"6","author":"Raj","year":"2021","journal-title":"ACS Omega"},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib60","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41429-018-0027-1","article-title":"Anti-Helicobacter pylori activities of selected N-substituted cinnamamide derivatives evaluated on reference and clinical bacterial strains","volume":"71","author":"Klesiewicz","year":"2018","journal-title":"J. Antibiot."},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib61","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtcme.2019.05.002","article-title":"Syzygium aromaticum L.: traditional herbal medicine against cagA and vacA toxin genes-producing drug resistant Helicobacter pylori","volume":"10","author":"El-Shouny","year":"2020","journal-title":"J. Traditional Complement. Med."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2180-13-103","article-title":"Antibacterial activities of almond skins on cagA-positive and-negative clinical isolates of Helicobacter pylori","volume":"13","author":"Bisignano","year":"2013","journal-title":"BMC Microbiol."},{"issue":"18","key":"10.1016\/j.micpath.2025.108060_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810035","article-title":"Hesperetin inhibits expression of virulence factors and growth of Helicobacter pylori","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030176","article-title":"Inhibition of mutation and combating the evolution of antibiotic resistance","volume":"3","author":"Cirz","year":"2005","journal-title":"PLoS Biol."},{"issue":"12","key":"10.1016\/j.micpath.2025.108060_bib65","article-title":"A novel reduction strategy of clarithromycin resistance in Helicobacter pylori","volume":"7","author":"Tadjrobehkar","year":"2014","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.micpath.2025.108060_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152968","article-title":"Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-\u03baB signaling","volume":"63","author":"Su","year":"2019","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.14202\/vetworld.2021.120-128","article-title":"Novel in vitro and in vivo anti-Helicobacter pylori effects of pomegranate peel ethanol extract","volume":"14","author":"Mayyas","year":"2021","journal-title":"Vet. World"},{"issue":"7","key":"10.1016\/j.micpath.2025.108060_bib68","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/(SICI)1099-1573(199611)10:7<616::AID-PTR897>3.0.CO;2-N","article-title":"Hesperidin and neohesperidin dihydrochalcone on different experimental models of induced gastric ulcer","volume":"10","author":"Suarez","year":"1996","journal-title":"Phytother Res."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-017-0546-y","article-title":"Protective effects of orange (Citrus sinensis L.) peel aqueous extract and hesperidin on oxidative stress and peptic ulcer induced by alcohol in rat","volume":"16","author":"Selmi","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib70","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MCG.0b013e3181c21c69","article-title":"Can Helicobacter pylori invade human gastric mucosa?: an in vivo study using electron microscopy, immunohistochemical methods, and real-time polymerase chain reaction","volume":"44","author":"\u00d6zbek","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib71","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/48.6.923","article-title":"Localization of [14C] amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin","volume":"48","author":"Endo","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib72","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/jac\/dkf097","article-title":"Localization of [14C] clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin","volume":"50","author":"Endo","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib73","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/10611860902718649","article-title":"Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori","volume":"17","author":"Ramteke","year":"2009","journal-title":"J. Drug Target."},{"issue":"21","key":"10.1016\/j.micpath.2025.108060_bib74","doi-asserted-by":"crossref","first-page":"12619","DOI":"10.1073\/pnas.95.21.12619","article-title":"Free recombination within Helicobacter pylori","volume":"95","author":"Suerbaum","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.micpath.2025.108060_bib75","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H pylori antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"M\u00e9graud","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib76","first-page":"78","article-title":"Targeted nanotherapeutics for the treatment of Helicobacter pylori infection","volume":"31","author":"Chitas","year":"2024"},{"key":"10.1016\/j.micpath.2025.108060_bib77","series-title":"Forging a New Frontier: Antimicrobial Peptides and Nanotechnology Converging to Conquer Gastrointestinal Pathogens","author":"Carnero Canales","year":"2025"},{"issue":"10","key":"10.1016\/j.micpath.2025.108060_bib78","first-page":"2658","article-title":"Phosphatidylethanolamine of Helicobacter pylori functions as a steroid-binding lipid in the assimilation of free cholesterol and 3\u03b2-hydroxl steroids into the bacterial cell membrane","volume":"194","author":"Shimomura","year":"2012"},{"issue":"10","key":"10.1016\/j.micpath.2025.108060_bib79","first-page":"1866","article-title":"The anti-oxidant curcumin solubilized as oil-in-water nanoemulsions or chitosan nanocapsules effectively reduces helicobacter pylori growth, bacterial biofilm formation","volume":"12","author":"Hidalgo","year":"2023","journal-title":"Gastric Cell Adhesion Internalization"},{"key":"10.1016\/j.micpath.2025.108060_bib80","series-title":"Technology, Optimization and Bactericidal Inhibitory Activities of Nanostructured Lipid Carrier-Mediated Co-delivery of Myricetin and Amoxicillin for Eradication of Helicobacter pylori in Vitro","author":"Khan","year":"2025"},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib81","article-title":"Yogurt-inspired hybrid membrane vesicles for the prevention and treatment of Helicobacter pylori infection","volume":"1","author":"Liu","year":"2025"},{"issue":"8","key":"10.1016\/j.micpath.2025.108060_bib82","first-page":"613","article-title":"Unveiling the potential role of micro\/nano biomaterials in the treatment of Helicobacter pylori infection","volume":"22","author":"Fathi Kisomi","year":"2024"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib83","article-title":"Biomaterials for Helicobacter pylori therapy: therapeutic potential and future perspectives","volume":"14","author":"Lai","year":"2022"},{"key":"10.1016\/j.micpath.2025.108060_bib84","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.2147\/IJN.S146195","article-title":"Nanotechnology-based drug delivery systems for control of microbial biofilms: a review","volume":"13","author":"Ramos","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2025.108060_bib85","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2147\/IJN.S41695","article-title":"Preparation and characterization of flexible nanoliposomes loaded with daptomycin, a novel antibiotic, for topical skin therapy","volume":"8","author":"Li","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"13\u201314","key":"10.1016\/j.micpath.2025.108060_bib86","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.addr.2013.07.011","article-title":"Nanotechnology as a therapeutic tool to combat microbial resistance","volume":"65","author":"Pelgrift","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pharmaceutics12030288","article-title":"Nanostructured lipid carriers for delivery of chemotherapeutics: a review","volume":"12","author":"Haider","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2025.108060_bib88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","article-title":"Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier","volume":"51","author":"Salvi","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","article-title":"Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?","volume":"47","author":"Das","year":"2012","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.micpath.2025.108060_bib90","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejps.2018.06.017","article-title":"Optimization of nanostructured lipid carriers for Zidovudine delivery using a microwave-assisted production method","volume":"122","author":"Cavalcanti","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib91","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00253-019-10234-1","article-title":"BabA and LPS inhibitors against Helicobacter pylori: pectins and pectin-like rhamnogalacturonans as adhesion blockers","volume":"104","author":"Gottesmann","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib92","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2012.04.036","article-title":"Protein-based nanocarriers as promising drug and gene delivery systems","volume":"161","author":"Elzoghby","year":"2012","journal-title":"J. Contr. Release"},{"issue":"13","key":"10.1016\/j.micpath.2025.108060_bib93","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1007\/s00253-020-10647-3","article-title":"Smart drug delivery against Helicobacter pylori: pectin-coated, mucoadhesive liposomes with antiadhesive activity and antibiotic cargo","volume":"104","author":"Gottesmann","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.108060_bib94","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2147\/IJN.S151825","article-title":"The impact of liposomal linolenic acid on gastrointestinal microbiota in mice","volume":"13","author":"Li","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"49","key":"10.1016\/j.micpath.2025.108060_bib95","doi-asserted-by":"crossref","first-page":"17600","DOI":"10.1073\/pnas.1418230111","article-title":"In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation","volume":"111","author":"Thamphiwatana","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.micpath.2025.108060_bib96","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.foodhyd.2018.03.001","article-title":"Influence of essential oils and pectin on nanoemulsion formulation: a ternary phase experimental approach","volume":"81","author":"Artiga-Artigas","year":"2018","journal-title":"Food Hydrocoll."},{"key":"10.1016\/j.micpath.2025.108060_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lwt.2016.11.022","article-title":"Physicochemical characterization of chitosan nanoparticles and nanocapsules incorporated with lime essential oil and their antibacterial activity against food-borne pathogens","volume":"77","author":"Sotelo-Boy\u00e1s","year":"2017","journal-title":"Lebensm. Wiss. Technol."},{"issue":"11","key":"10.1016\/j.micpath.2025.108060_bib98","first-page":"1231","article-title":"Antifungal activity of Zataria multiflora essential oil-loaded solid lipid nanoparticles in-vitro condition","volume":"19","author":"Nasseri","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"9","key":"10.1016\/j.micpath.2025.108060_bib99","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1021\/mp300243w","article-title":"Antibacterial activities of liposomal linolenic acids against antibiotic-resistant Helicobacter pylori","volume":"9","author":"Obonyo","year":"2012","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116519","article-title":"Mechanism of antibacterial activity of liposomal linolenic acid against Helicobacter pylori","volume":"10","author":"Jung","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.micpath.2025.108060_bib101","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1021\/mp500584u","article-title":"Dextrin\u2013colistin conjugates as a model bioresponsive treatment for multidrug resistant bacterial infections","volume":"11","author":"Ferguson","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.micpath.2025.108060_bib102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jare.2018.01.006","article-title":"Helicobacter pylori urease for diagnosis of Helicobacter pylori infection: a mini review","volume":"13","author":"Graham","year":"2018","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib103","first-page":"85","article-title":"Microbial ureases: significance, regulation, and molecular characterization","volume":"53","author":"Mobley","year":"1989","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.micpath.2025.108060_bib104","doi-asserted-by":"crossref","DOI":"10.1152\/physiol.00032.2005","article-title":"Acid acclimation by Helicobacter pylori","author":"Sachs","year":"2005","journal-title":"Physiology"},{"issue":"11","key":"10.1016\/j.micpath.2025.108060_bib105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1046\/j.1365-2036.2000.00837.x","article-title":"The control of gastric acid and Helicobacter pylori eradication","volume":"14","author":"Sachs","year":"2000","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib106","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/IAI.68.2.470-477.2000","article-title":"Expression of the Helicobacter pylori ureI gene is required for acidic pH activation of cytoplasmic urease","volume":"68","author":"Scott","year":"2000","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib107","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/35073084","article-title":"Living dangerously: how Helicobacter pylori survives in the human stomach","volume":"2","author":"Montecucco","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"30","key":"10.1016\/j.micpath.2025.108060_bib108","doi-asserted-by":"crossref","first-page":"18277","DOI":"10.1039\/C6RA27872H","article-title":"Molecular docking, molecular dynamics simulation, biological evaluation and 2D QSAR analysis of flavonoids from Syzygium alternifolium as potent anti-Helicobacter pylori agents","volume":"7","author":"Babu","year":"2017","journal-title":"RSC Adv."},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib109","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1365-2958.2000.01918.x","article-title":"Identification of the urease operon in Helicobacter pylori and its control by mRNA decay in response to pH","volume":"36","author":"Akada","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2025.108060_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104896","article-title":"Co-delivery of hesperidin and clarithromycin in a nanostructured lipid carrier for the eradication of Helicobacter pylori in vitro","volume":"112","author":"Sharaf","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"9","key":"10.1016\/j.micpath.2025.108060_bib111","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1021\/ja211279u","article-title":"Lipase-sensitive polymeric triple-layered nanogel for \u201con-demand\u201d drug delivery","volume":"134","author":"Xiong","year":"2012","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib112","first-page":"1076","article-title":"Solid lipid nanoparticles delivering a DNA vaccine encoding Helicobacter pylori Urease A Subunit: immune analyses before and after a mouse model of","volume":"25","author":"Francis","year":"2024","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib113","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/00222615-35-4-197","article-title":"Adherence of Helicobacter pylori to human gastric epithelial cells in vitro","volume":"35","author":"Hemalatha","year":"1991","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2025.108060_bib114","series-title":"Targeting Strategies for the Treatment of Helicobacter pylori Infections, Nano Based Drug Delivery","first-page":"604","author":"Lopes","year":"2015"},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib115","first-page":"fuaa047","article-title":"Eco-evolutionary feedbacks mediated by bacterial membrane vesicles","volume":"45","author":"Zlatkov","year":"2021","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib116","first-page":"407","article-title":"Alteration in the composition of cholesteryl glucosides and other lipids in Helicobacter pylori undergoing morphological change from spiral to coccoid form","volume":"237","author":"Shimomura","year":"2004","journal-title":"FEMS Microbiol. Lett."},{"issue":"10","key":"10.1016\/j.micpath.2025.108060_bib117","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1128\/JB.00105-12","article-title":"Phosphatidylethanolamine of Helicobacter pylori functions as a steroid-binding lipid in the assimilation of free cholesterol and 3\u03b2-hydroxl steroids into the bacterial cell membrane","volume":"194","author":"Shimomura","year":"2012","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2025.108060_bib118","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2147\/IJN.S193992","article-title":"Delivering amoxicillin at the infection site\u2013a rational design through lipid nanoparticles","volume":"14","author":"Lopes-de-Campos","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib119","first-page":"368","article-title":"Double liposomes mediated dual drug targeting for treatment of Helicobacter pylori infections, Die Pharmazie-An International","volume":"66","author":"Singh","year":"2011","journal-title":"J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2004.06.006","article-title":"Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori","volume":"99","author":"Umamaheshwari","year":"2004","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.micpath.2025.108060_bib121","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2017.12.010","article-title":"Nanomaterials and molecular transporters to overcome the bacterial envelope barrier: towards advanced delivery of antibiotics","volume":"136","author":"Santos","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2025.108060_bib122","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.2147\/IJN.S55807","article-title":"Fusion between fluid liposomes and intact bacteria: study of driving parameters and in vitro bactericidal efficacy","volume":"11","author":"Wang","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2025.108060_bib123","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.2147\/IJN.S42617","article-title":"Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium","volume":"8","author":"Ma","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib124","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ijantimicag.2010.01.015","article-title":"Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria","volume":"35","author":"Nicolosi","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib125","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1128\/AAC.40.3.665","article-title":"Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection","volume":"40","author":"Beaulac","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib126","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0005-2736(99)00217-5","article-title":"Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells","volume":"1463","author":"Sachetelli","year":"2000","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib127","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/41.1.35","article-title":"In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria","volume":"41","author":"Beaulac","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/mp8002539","article-title":"Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection","volume":"6","author":"Jain","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.micpath.2025.108060_bib129","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.2147\/IJN.S34312","article-title":"Dual drug delivery system for targeting H. pylori in the stomach: preparation and in vitro characterization of amoxicillin-loaded Carbopol\u00ae nanospheres","volume":"7","author":"Harsha","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2025.108060_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajg.2021.06.002","article-title":"Synthesis and characterization of amoxicillin-loaded polymeric nanocapsules as a drug delivery system targeting Helicobacter pylori","author":"Abdelghany","year":"2021","journal-title":"Arab J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.201800016","article-title":"Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection","volume":"1","author":"Angsantikul","year":"2018","journal-title":"Adv. Therapeut."},{"issue":"33","key":"10.1016\/j.micpath.2025.108060_bib132","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1002\/anie.201906280","article-title":"Inhibition of pathogen adhesion by bacterial outer membrane\u2010coated nanoparticles","volume":"58","author":"Zhang","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib133","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S596","article-title":"Drug delivery and nanoparticles: applications and hazards","volume":"3","author":"De Jong","year":"2008","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib134","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ijpharm.2015.09.055","article-title":"Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro","volume":"495","author":"Cai","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep18877","article-title":"Potent antibacterial nanoparticles against biofilm and intracellular bacteria","volume":"6","author":"Mu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.108060_bib136","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2019.02.039","article-title":"Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm","volume":"300","author":"Li","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.micpath.2025.108060_bib137","article-title":"Can rhamnose-based glycolipids nanoparticles be an alternative to fight biofilms on medical devices?","author":"Tom\u00e9","year":"2020","journal-title":"Copernicus Meet."},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib138","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/09205063.2020.1870323","article-title":"Chitosan-based nanoparticles as delivery-carrier for promising antimicrobial glycolipid biosurfactant to improve the eradication rate of Helicobacter pylori biofilm","volume":"32","author":"Arif","year":"2021","journal-title":"J. Biomater. Sci."},{"key":"10.1016\/j.micpath.2025.108060_bib139","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jconrel.2020.09.025","article-title":"Antibacterial self-assembled nanodrugs composed of berberine derivatives and rhamnolipids against Helicobacter pylori","volume":"328","author":"Shen","year":"2020","journal-title":"J. Contr. Release"},{"issue":"33","key":"10.1016\/j.micpath.2025.108060_bib140","first-page":"29086","volume":"7","author":"Wu","year":"2022","journal-title":"Cosmetic-derived Mannosylerythritol lipid-B-phospholipid nanoliposome: an acid-stabilized carrier for efficient Gastromucosal delivery of amoxicillin for in vivo treatment of Helicobacter pylori"},{"key":"10.1016\/j.micpath.2025.108060_bib141","first-page":"105","volume":"193","author":"Cheng","year":"2023","journal-title":"Biopharmaceutics, Berberine-loaded mannosylerythritol lipid-B nanomicelles as drug delivery carriers for the treatment of Helicobacter pylori biofilms in vivo"},{"key":"10.1016\/j.micpath.2025.108060_bib142","volume":"vol. 16","author":"Lei","year":"2025"},{"key":"10.1016\/j.micpath.2025.108060_bib143","series-title":"The Next Frontier: Unveiling Novel Approaches for Combating Multidrug-Resistant Bacteria","first-page":"1","author":"Mallari","year":"2025"},{"key":"10.1016\/j.micpath.2025.108060_bib144","volume":"308","author":"Sun","year":"2024"},{"issue":"12","key":"10.1016\/j.micpath.2025.108060_bib145","first-page":"388","article-title":"Current treatment strategies against multidrug-resistant bacteria","volume":"79","author":"Parmanik","year":"2022","journal-title":"a review"},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib146","doi-asserted-by":"crossref","first-page":"531","DOI":"10.5009\/gnl19136","article-title":"Ten-day concomitant, 10-day sequential, and 7-day triple therapy as first-line treatment for Helicobacter pylori infection: a nationwide randomized trial in Korea","volume":"13","author":"Kim","year":"2019","journal-title":"Gut and liver"},{"issue":"11","key":"10.1016\/j.micpath.2025.108060_bib147","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/ajg.2011.309","article-title":"WillH. PyloriStagger under the weight of this load? A novel but expensive eradication regimen","volume":"106","author":"Watson","year":"2011","journal-title":"Official J. Am. Collegen Gastroenterol. ACG"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib148","first-page":"129","article-title":"A novel hybrid first-line therapy for H. pylori eradication: results of a pilot study","volume":"28","author":"De Francesco","year":"2019","journal-title":"J. Gastrointestinal Liver Dis.: JGLD"},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib149","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/JCMA.0000000000000256","article-title":"Reverse hybrid therapy achieves a similar eradication rate as standard hybrid therapy for Helicobacter pylori infection","volume":"83","author":"Lin","year":"2020","journal-title":"J. Chin. Med. Assoc."},{"issue":"10","key":"10.1016\/j.micpath.2025.108060_bib150","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/jgh.15034","article-title":"Equivalent efficacies of reverse hybrid and concomitant therapies in first\u2010line treatment of Helicobacter pylori infection","volume":"35","author":"Hsu","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.micpath.2025.108060_bib151","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/antibiotics9080436","article-title":"Best Helicobacter pylori eradication strategy in the era of antibiotic resistance","volume":"9","author":"Kim","year":"2020","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib152","doi-asserted-by":"crossref","first-page":"437","DOI":"10.14309\/ajg.0000000000000132","article-title":"Eradication efficacy of modified dual therapy compared with bismuth-containing quadruple therapy as a first-line treatment of Helicobacter pylori","volume":"114","author":"Yang","year":"2019","journal-title":"Official J. Am. Collegen Gastroenterol. ACG"},{"key":"10.1016\/j.micpath.2025.108060_bib153","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820937115","article-title":"High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: a systematic review with meta-analysis","volume":"13","author":"Zhu","year":"2020","journal-title":"Therapeutic Adv. Gastroenterol."},{"key":"10.1016\/j.micpath.2025.108060_bib154","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819858511","article-title":"Current status of first-and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients","volume":"12","author":"Mori","year":"2019","journal-title":"Therapeutic Adv. Gastroenterol."},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib155","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1159\/000501608","article-title":"A triple-drug blister-packaged drug with vonoprazan improves first-line eradication of Helicobacter pylori in elderly patients: a retrospective propensity score-matched cohort study","volume":"101","author":"Nishida","year":"2020","journal-title":"Digestion"},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib156","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000490889","article-title":"Smoking and drinking did not increase the failure of therapeutic Helicobacter pylori eradication by vonoprazan, clarithromycin, and amoxicillin","volume":"99","author":"Takara","year":"2019","journal-title":"Digestion"},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib157","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/jgh.14456","article-title":"Randomized trial of vonoprazan\u2010based versus proton\u2010pump inhibitor\u2010based third\u2010line triple therapy with sitafloxacin for Helicobacter pylori","volume":"34","author":"Sue","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib158","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/cancers11010116","article-title":"Vonoprazan-based third-line therapy has a higher eradication rate against sitafloxacin-resistant Helicobacter pylori","volume":"11","author":"Saito","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib159","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1159\/000502287","article-title":"Dual therapy with vonoprazan and amoxicillin is as effective as triple therapy with vonoprazan, amoxicillin and clarithromycin for eradication of Helicobacter pylori","volume":"101","author":"Furuta","year":"2020","journal-title":"Digestion"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cgh.2019.03.048","article-title":"Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90% of patients","volume":"18","author":"McNicholl","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib161","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12615","article-title":"Once\u2010daily rabeprazole, levofloxacin, clarithromycin\u2010MR, and bismuth for Helicobacter pylori eradication: a randomized study of 7 or 14 days (ONCE study)","volume":"24","author":"Auttajaroon","year":"2019","journal-title":"Helicobacter"},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib162","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12591","article-title":"Effectiveness and safety of furazolidone\u2010containing quadruple regimens in patients with Helicobacter pylori infection in real\u2010world practice","volume":"24","author":"Song","year":"2019","journal-title":"Helicobacter"},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib163","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12546","article-title":"Bismuth\u2010containing quadruple therapy versus concomitant quadruple therapy as first\u2010line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: a prospective, cross\u2010sectional, comparative, open trial","volume":"24","author":"Mac\u00edas\u2010Garc\u00eda","year":"2019","journal-title":"Helicobacter"},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib164","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12606","article-title":"Pylera\u00ae plus ranitidine vs Pylera\u00ae plus esomeprazole in first\u2010line treatment of Helicobacter pylori infection: two pilot studies","volume":"24","author":"Ciccaglione","year":"2019","journal-title":"Helicobacter"},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177455","article-title":"The association between vacA or cagA status and eradication outcome of Helicobacter pylori infection: a meta-analysis","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib166","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014408","volume":"98","author":"Yi","year":"2019","journal-title":"Medicine"},{"issue":"14","key":"10.1016\/j.micpath.2025.108060_bib167","doi-asserted-by":"crossref","first-page":"R713","DOI":"10.1016\/j.cub.2017.05.064","article-title":"Animal communication: when i'm calling you, will you answer too?","volume":"27","author":"Vickers","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.micpath.2025.108060_bib168","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jep.2018.01.012","article-title":"Pharmacological activities of the organic extracts and fatty acid composition of the petroleum ether extract from Haplophyllum tuberculatum leaves","volume":"216","author":"Hamdi","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib169","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jsps.2018.02.002","article-title":"In\u2013Vitro activity of Desmostachya bipinnata (L.) Stapf successive extracts against Helicobacter pylori clinical isolates","volume":"26","author":"Ibrahim","year":"2018","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.micpath.2025.108060_bib170","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.prostaglandins.2018.01.003","article-title":"Lysophosphatidic acid in medicinal herbs enhances prostaglandin E2 and protects against indomethacin-induced gastric cell damage in vivo and in vitro","volume":"135","author":"Afroz","year":"2018","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.micpath.2025.108060_bib171","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jep.2017.09.004","article-title":"Anti-ulcer and anti-Helicobacter pylori potentials of the ethyl acetate fraction of Physalis alkekengi L. var. franchetii (Solanaceae) in rodent","volume":"211","author":"Wang","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micpath.2025.108060_bib172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2018.12.032","article-title":"In vitro and in vivo anti-Helicobacter pylori activity of Casearia sylvestris leaf derivatives","volume":"233","author":"Sp\u00f3sito","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib173","doi-asserted-by":"crossref","first-page":"143","DOI":"10.21608\/aprh.2019.14036.1085","article-title":"Validated HPLC determination of the potential anti-Helicobacter pylori, lepidine, in lepidium sativum seeds assessed by molecular docking study","volume":"3","author":"El Haddad","year":"2019","journal-title":"J. Adv. Pharmacy Res."},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib174","article-title":"In vitro anti-Helicobacter pylori activity of berberine and barberry extracts: a preliminary report","volume":"14","author":"Koci\u0107","year":"2019","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.micpath.2025.108060_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.eujim.2019.100957","article-title":"Inhibitory effect of medicinal plants from Cameroon on the growth and adhesion of Helicobacter pylori","volume":"30","author":"Ngnameko","year":"2019","journal-title":"European J. Integrative Med."},{"key":"10.1016\/j.micpath.2025.108060_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103559","article-title":"The in vitro cytotoxicity, antioxidant and antibacterial potential of Satureja hortensis L. essential oil cultivated in Egypt","volume":"95","author":"Abou Baker","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib177","first-page":"1","article-title":"Ethyl acetate extract of Kaempferia parviflora inhibits Helicobacter pylori-associated mammalian cell inflammation by regulating proinflammatory cytokine expression and leukocyte chemotaxis","volume":"20","author":"Nemidkanam","year":"2020","journal-title":"BMC Complement. Med. Therapies"},{"key":"10.1016\/j.micpath.2025.108060_bib178","first-page":"1","article-title":"Two clerodane diterpenes isolated from Polyalthia longifolia leaves: comparative structural features, anti-histaminic and anti-Helicobacter pylori activities","author":"Edmond","year":"2020","journal-title":"Nat. Prod. Res."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib179","doi-asserted-by":"crossref","first-page":"158","DOI":"10.20307\/nps.2020.26.2.158","article-title":"Anti-Helicobacter pylori activity of compounds isolated from Fraxinus mandshurica bark","volume":"26","author":"Akter","year":"2020","journal-title":"Nat. Prod. Sci."},{"issue":"4","key":"10.1016\/j.micpath.2025.108060_bib180","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/14786419.2018.1488711","article-title":"Linking traditional anti-ulcer use of rhizomes of Bergenia ciliata (Haw.) to its anti-Helicobacter pylori constituents","volume":"34","author":"Ali","year":"2020","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.micpath.2025.108060_bib181","article-title":"Preparation, urease inhibition mechanisms, and anti-Helicobacter pylori activities of hesperetin-7-rhamnoglucoside","author":"Sharaf","year":"2021","journal-title":"Curr. Res. Microb. Sci."},{"key":"10.1016\/j.micpath.2025.108060_bib182","article-title":"In vitro antibacterial activity of nimbolide against Helicobacter pylori","author":"Wylie","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.micpath.2025.108060_bib183","series-title":"Urease Enzyme Production and Epithelial Cell Adhesion","article-title":"Inhibitory efficacy of Camellia sinensis leaf and medicinal plant extracts on Helicobacter pylori standard and isolate strains growth","author":"Kaewkod","year":"2021"},{"issue":"8","key":"10.1016\/j.micpath.2025.108060_bib184","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/pathogens10081033","article-title":"Antibiofilm and antimicrobial-enhancing activity of chelidonium majus and corydalis cheilanthifolia extracts against multidrug-resistant Helicobacter pylori","volume":"10","author":"Krzy\u017cek","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2025.108060_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114578","article-title":"In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album Raeusch. fruit extracts","volume":"283","author":"Yan","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.micpath.2025.108060_bib186","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/antibiotics11091252","article-title":"In situ biosynthesis of reduced alpha hematite (\u03b1-Fe2O3) nanoparticles by stevia rebaudiana L. Leaf extract: insights into antioxidant, antimicrobial, and anticancer properties","volume":"11","author":"Alshawwa","year":"2022","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.micpath.2025.108060_bib187","first-page":"476","article-title":"Anti-Helicobacter pylori compounds from oliveria decumbens vent","volume":"20","author":"Eftekhari","year":"2021","journal-title":"through urease inhibitory in-vitro in-silico studies"},{"key":"10.1016\/j.micpath.2025.108060_bib188","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.colsurfb.2018.11.057","article-title":"Enhanced oral bioavailability and brain uptake of Darunavir using lipid nanoemulsion formulation","volume":"175","author":"Desai","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib189","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1039\/C8FO02069H","article-title":"Impact of emulsifier nature and concentration on the stability of \u03b2-carotene enriched nanoemulsions during in vitro digestion","volume":"10","author":"Gasa-Falcon","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.micpath.2025.108060_bib190","article-title":"Tamoxifen\/raloxifene loaded liposomes for oral treatment of breast cancer","volume":"57","author":"A\u011fardan","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"7","key":"10.1016\/j.micpath.2025.108060_bib191","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12272-018-1046-y","article-title":"Preparation, characterization, and pharmacokinetics of liposomal docetaxel for oral administration","volume":"41","author":"Kim","year":"2018","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"7","key":"10.1016\/j.micpath.2025.108060_bib192","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1208\/s12249-018-1118-9","article-title":"Labrasol-enriched nanoliposomal formulation: novel approach to improve oral absorption of water-insoluble drug, carvedilol","volume":"19","author":"Ghassemi","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1437-5","article-title":"Formulation of dronedarone hydrochloride-loaded proliposomes: in vitro and in vivo evaluation using Caco-2 and rat model","volume":"20","author":"Kovvasu","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"23","key":"10.1016\/j.micpath.2025.108060_bib194","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2217\/nnm-2018-0238","article-title":"Elaboration of polymersomes versus conventional liposomes for improving oral bioavailability of the anticancer flutamide","volume":"13","author":"Youssef","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.micpath.2025.108060_bib195","article-title":"The effect of efflux pump inhibitors on in vitro and in vivo efficacy of solid lipid nanoparticles containing SN38","volume":"60","author":"Nasirizadeh","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"8","key":"10.1016\/j.micpath.2025.108060_bib196","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1080\/03639045.2019.1593434","article-title":"Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, in vitro characterization, cell line studies and in vivo efficacy in schizophrenia","volume":"45","author":"Patel","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib197","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/21691401.2018.1546186","article-title":"Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies","volume":"47","author":"Patel","year":"2019","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"key":"10.1016\/j.micpath.2025.108060_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111073","article-title":"Pharmacodynamic, pharmacokinetic and physical characterization of cilnidipine loaded solid lipid nanoparticles for oral delivery optimized using the principles of design of experiments","volume":"193","author":"Diwan","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib199","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154926","article-title":"Alendronate sodium as enteric coated solid lipid nanoparticles; preparation, optimization, and in vivo evaluation to enhance its oral bioavailability","volume":"11","author":"Hosny","year":"2016","journal-title":"PLoS One"},{"issue":"36","key":"10.1016\/j.micpath.2025.108060_bib200","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.2174\/1381612826666200614175236","article-title":"Nanostructured lipid carriers as potential drug delivery systems for skin disorders","volume":"26","author":"Waghule","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.micpath.2025.108060_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2020.124414","article-title":"Efficacy of Mentha pulegium essential oil encapsulated into nanostructured lipid carriers as an in vitro antibacterial and infected wound healing agent","volume":"589","author":"Khezri","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib202","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/2211738508999201105142945","article-title":"Antimicrobial activity of nanostructured lipid carriers loaded Punica granatum seed oil against Staphylococcus epidermidis","volume":"8","author":"Fathi","year":"2020","journal-title":"Pharm. Nanotechnol."},{"issue":"41","key":"10.1016\/j.micpath.2025.108060_bib203","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ac1098","article-title":"Exemestane encapsulated polymer-lipid hybrid nanoparticles for improved efficacy against breast cancer: optimization, in vitro characterization and cell culture studies","volume":"32","author":"Rizwanullah","year":"2021","journal-title":"Nanotechnology"},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib204","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2019.09.004","article-title":"Improved oral delivery of tilianin through lipid\u2013polymer hybrid nanoparticles to enhance bioavailability","volume":"519","author":"Zeng","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.micpath.2025.108060_bib205","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.2147\/IJN.S261764","article-title":"Ethosome-derived invasomes as a potential transdermal delivery system for vardenafil hydrochloride: development, optimization and application of physiologically based pharmacokinetic modeling in adults and geriatrics","volume":"15","author":"Ammar","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2025.108060_bib206","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jddst.2017.11.005","article-title":"Curcumin loaded ethosomes for transdermal application: formulation, optimization, in-vitro and in-vivo study","volume":"44","author":"Pathan","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"5","key":"10.1016\/j.micpath.2025.108060_bib207","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/pharmaceutics13050648","article-title":"Design and optimization of orally administered luteolin nanoethosomes to enhance its anti-tumor activity against hepatocellular carcinoma","volume":"13","author":"Elsayed","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.micpath.2025.108060_bib208","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijpharm.2015.11.011","article-title":"Evaluation of critical formulation parameters in design and differentiation of self-microemulsifying drug delivery systems (SMEDDSs) for oral delivery of aciclovir","volume":"497","author":"Jankovi\u0107","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.micpath.2025.108060_bib209","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.xphs.2019.07.004","article-title":"A Self-nanoemulsifying drug delivery system for enhancing the oral bioavailability of candesartan cilexetil: ex vivo and in vivo evaluation","volume":"108","author":"AboulFotouh","year":"2019","journal-title":"J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.micpath.2025.108060_bib210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/10837450.2019.1683749","article-title":"Enhanced oral bioavailability of valsartan in rats using a supersaturable self-microemulsifying drug delivery system with P-glycoprotein inhibitors","volume":"25","author":"Goo","year":"2020","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.micpath.2025.108060_bib211","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.2147\/IJN.S211014","article-title":"Self-microemulsifying drug delivery system (SMEDDS) for improved oral delivery and photostability of methotrexate","volume":"14","author":"Kim","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib212","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/10717544.2019.1616237","article-title":"Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy","volume":"26","author":"Cui","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.micpath.2025.108060_bib213","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3389\/fonc.2019.00978","article-title":"Development of triptolide self-microemulsifying drug delivery system and its anti-tumor effect on gastric cancer xenografts","volume":"9","author":"Xie","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.micpath.2025.108060_bib214","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.colsurfb.2012.06.031","article-title":"Development of solid self-nanoemulsifying granules (SSNEGs) of ondansetron hydrochloride with enhanced bioavailability potential","volume":"101","author":"Beg","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"10","key":"10.1016\/j.micpath.2025.108060_bib215","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3109\/03639045.2011.565774","article-title":"Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems","volume":"37","author":"Wang","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.micpath.2025.108060_bib216","article-title":"Immunoinformatics design and synthesis of a multi-epitope vaccine against Helicobacter pylori based on lipid nanoparticles","volume":"14","author":"Jebali","year":"2024"},{"issue":"6","key":"10.1016\/j.micpath.2025.108060_bib217","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s11095-006-0022-2","article-title":"Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules","volume":"23","author":"Peltier","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.micpath.2025.108060_bib218","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2019.02.013","article-title":"Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin","volume":"560","author":"Bapat","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.micpath.2025.108060_bib219","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.2147\/IJN.S200666","article-title":"Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K\/Akt pathways","volume":"14","author":"de Oliveira","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2025.108060_bib220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijbiomac.2017.05.015","article-title":"Lipid drug conjugate nanoparticle as a potential nanocarrier for the oral delivery of pemetrexed diacid: formulation design, characterization, ex vivo, and in vivo assessment","volume":"103","author":"Soni","year":"2017","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025007855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025007855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T09:07:36Z","timestamp":1763370456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025007855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":220,"alternative-id":["S0882401025007855"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108060","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advance Helicobacter pylori eradication: Current therapeutic strategies and the potential of lipid-based nanocarriers for targeting receptors","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108060"}}